Latest News & Features
Americas
American pharmaceutical company Merck & Co. has secured a victory against its rival Pfizer in an inter partes review of a patent concerning Prevnar 13, the biggest-selling vaccine in the world. 14 March 2019
Americas
The Trump administration has named Ned Sharpless, director of the National Cancer Institute, as the Food and Drug Administration's (FDA) acting commissioner. 13 March 2019
Americas
Press releases in recent months that suggest the CRISPR IP saga is about to end are too optimistic and miss out many of the nuances of the current situation, according to Claire Irvine, partner at HGF. 13 March 2019
Big Pharma
India’s government has cut the royalties its local seed companies and farmers pay to Monsanto by almost 50%. 13 March 2019
Biotechnology
The 13th annual BIO-Europe Spring 2019 global life science partnering event will be held March 25–27 in Vienna, Austria. Guadalupe Rodriguez and Kit Muller of EBD Group report. 12 March 2019
Europe
Switzerland-based Novartis today, March 12, failed to convince the EU General Court that its ‘Smartsurface’ trademark should be registered for contact lenses. 12 March 2019
Americas
The US Patent and Trademark Office has issued a third CRISPR patent to inventor Emmanuelle Charpentier, one of the key figures in the CRISPR landscape. 12 March 2019
Americas
Pharmaceutical distributor CanaRx Services has hit back at criticism from the US Food and Drug Administration over the Canadian company’s alleged supply of unapproved and misbranded drugs. 11 March 2019
Big Pharma
King’s College London has entered a licensing and collaboration agreement with US pharmaceutical company Merck & Co to develop new chronic pain medications. 11 March 2019
article
The US Food and Drug Administration yesterday announced draft revisions to its policy on the naming of biosimilars, in an attempt to appease critics who say that renaming previously-licensed products is too expensive. 8 March 2019